Quantification of estrogen receptor α and β expression in sporadic breast cancer

被引:115
作者
Bièche, I
Parfait, B
Laurendeau, I
Girault, I
Vidaud, M
Lidereau, R
机构
[1] Univ Paris 05, Fac Sci Pharmaceut & Biol, UPRES JE 2195, Genet Mol Lab, F-75006 Paris, France
[2] Ctr Rene Huguenin, Lab Oncogenet, INSERM E0017, F-92211 St Cloud, France
关键词
breast cancer; estrogen receptor alpha; estrogen receptor beta; mRNA level; quantitative RT-PCR; real-time PCR detection;
D O I
10.1038/sj.onc.1204917
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The recent cloning of a second estrogen receptor (ER), designated ER beta, has prompted a reevaluation of the role of ERs in breast cancer. We have developed and validated a real-time RT - PCR assay to quantify ER alpha and ER beta gene expression at the mRNA level in a series of 131 patients with unilateral invasive primary breast cancer. Although ER beta expression showed wide variations in tumor tissues, its range (nearly three orders of magnitude) was smaller than that of ER alpha (nearly four orders of magnitude), suggesting that ER beta is more tightly controlled than ER alpha. We observed a negative correlation between ER alpha and ER beta expression. 'ER alpha -negative' tumors (containing very low ER alpha mRNA levels) were associated with SBR histopathological grade III, RB1 underexpression and ERBB2 overexpression, confirming that ER alpha negativity delineates poorly differentiated tumors. The amount of ER alpha mRNA (but not that of ER beta mRNA) increased with age and was consequently higher in postmenopausal patients' tumors. Expression of ER alpha (but not that of ER beta) also correlated strongly with progesterone receptor (PR) and PS2 expression, suggesting that ER alpha has stronger transcriptional activity than ER beta towards genes containing an ERE (estrogen response element) in their promoters. Interestingly, we found a negative correlation between the expression of ER beta (but not ER alpha) and CCND1, which contains an AP1 element but not an ERE in its promoter. Taken together, these data confirm that ER alpha and ER beta play different roles in breast cancer, partly by mediating the transcription of various genes via different types of DNA enhancer. PR and PS2 seem to be mainly ER alpha -responsive genes, whereas CCND1 may be mainly ER beta -responsive. Our findings also underline the need for a reliable method, providing full range of quantitative values, to determine ER alpha and ER beta status in the clinical setting.
引用
收藏
页码:8109 / 8115
页数:7
相关论文
共 27 条
  • [1] Bièche I, 2000, MOL CARCINOGEN, V29, P151, DOI 10.1002/1098-2744(200011)29:3<151::AID-MC4>3.0.CO
  • [2] 2-6
  • [3] Bièche I, 1999, CANCER RES, V59, P2759
  • [4] Bièche I, 1999, CLIN CHEM, V45, P1148
  • [5] HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS
    BLOOM, HJG
    RICHARDSON, WW
    [J]. BRITISH JOURNAL OF CANCER, 1957, 11 (03) : 359 - &
  • [6] Clarke M, 1998, LANCET, V351, P1451
  • [7] Positional cloning of ZNF217 and NABC1:: Genes amplified at 20q13.2 and overexpressed in breast carcinoma
    Collins, C
    Rommens, JM
    Kowbel, D
    Godfrey, T
    Tanner, M
    Hwang, S
    Polikoff, D
    Nonet, G
    Cochran, J
    Myambo, K
    Jay, KE
    Froula, J
    Cloutier, T
    Kuo, WL
    Yaswen, P
    Dairkee, S
    Giovanola, J
    Hutchinson, GB
    Isola, J
    Kallioniemi, OP
    Palazzolo, M
    Martin, C
    Ericsson, C
    Pinkel, D
    Albertson, D
    Li, WB
    Gray, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8703 - 8708
  • [8] Tumor characteristics and clinical outcome of elderly women with breast cancer
    Diab, SG
    Elledge, RM
    Clark, GM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (07) : 550 - 556
  • [9] Dotzlaw H, 1999, CANCER RES, V59, P529
  • [10] Fuqua SAW, 1999, CANCER RES, V59, P5425